Recent Articles from Reuters
Trump’s $100,000 H-1B visa fee draws legal challenge from US states
California and 18 states are suing to block Trump’s $100K H-1B visa fee, arguing it exceeds federal authority and threatens key industries.
Investors eager for delayed data to shed light on US economy
Delayed U.S. jobs and inflation reports will give markets fresh clarity after a government shutdown as investors assess Fed policy and year-end risks.
Trump’s semiconductor tariff plan likely delayed, officials say
US officials signal Trump’s planned 100% semiconductor tariffs may be delayed as the administration weighs China tensions and consumer price risks.
Novo Nordisk chair touts OTC future for Wegovy as top investor tightens grip
New Novo Nordisk chair Lars Rebien Sorensen plans to add pharma and OTC expertise after a board shake-up that sparked governance concerns.
Texas judge weighs Paxton bid to block Kenvue dividend
Texas AG Ken Paxton seeks to block Kenvue’s $398M dividend and restrict Tylenol marketing as a judge considers his unprecedented request.
US House report accuses China of minerals market interference
A House committee report alleges China manipulates global critical minerals prices and urges new U.S. policy controls and oversight.
Walmart CEO Doug McMillon to Retire; John Furner to Lead
Walmart CEO Doug McMillon will retire in 2026 after a decade transforming the retailer; U.S. chief John Furner named as his successor.
Metsera shareholders vote for up to $10 billion acquisition by Pfizer
(Reuters) -Metsera shareholders on Thursday approved Pfizer’s takeover offer worth up to $10 billion, according to a preliminary vote count, securing a critical re-entry into the lucrative obesity treatment market for the U.S. drug giant after a fierce bidding war with Wegovy-maker Novo Nordisk. The approval paves the way for Pfizer to diversify beyond its […]
Fed may soon start buying bonds to manage market liquidity, Williams says
New York Fed President John Williams said the central bank may soon restart bond purchases to maintain control of short-term rates.
Trump says 50-year mortgages would be no ‘big deal’
Trump calls 50-year mortgages minor, saying longer terms reduce monthly payments but delay homeownership and equity buildup.

















